A few years ago, a new NGS platform being announced at the Advances in Genome Biology and Technology (AGBT) meeting would not have been a surprise; multiple new instruments entered the NGS arena over ...
Illumina faces significant challenges from China's "unreliable entity list" and competition from Roche's new SBX technology, impacting its growth prospects. Despite a 37% stock decline since August, ...
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...
The FINANCIAL — Roche on August 19 announced that it has signed a definitive agreement to acquire Kapa Biosystems, Inc. (Kapa) a privately-held company headquartered in Wilmington, Massachusetts, US.
Roche is set to partner with Broad Clinical Labs for developing pilot applications leveraging its next-generation sequencing (NGS) Sequencing By Expansion (SBX) technology. This partnership aims to ...
Understanding Bioinformatics Workflows for NGS Analysis: Case Study with Whole-exome Sequencing Data
NGS enables the in-depth analysis of the genome and the identification and investigation of disease-associated variants–especially when workflows include target enrichment, which focuses on specific ...
The webinar series titled "The Basics of Next Generation Sequencing and its Application in Precision Oncology" aims to provide a comprehensive understanding of the fundamentals and practical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results